Lulicard Cream contains Luliconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections of the skin. Luliconazole exhibits broad-spectrum antifungal activity against dermatophytes, yeasts, and molds by inhibiting the biosynthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting cell membrane integrity and leading to fungal cell death. Lulicard Cream is primarily prescribed for conditions such as tinea corporis, tinea cruris, and tinea pedis caused by susceptible fungal pathogens. The cream formulation allows for effective penetration into the stratum corneum, facilitating rapid antifungal action and symptom relief. It is applied once daily to the affected area and surrounding skin, typically for a duration of 1 to 2 weeks, depending on the severity and location of the infection. Lulicard Cream is generally well tolerated, with adverse effects being infrequent and mild, including localized irritation, burning, or erythema. Patients should avoid contact with eyes and mucous membranes and discontinue use if hypersensitivity reactions occur. As a topical agent, systemic absorption is minimal, reducing the risk of systemic side effects. Lulicard Cream offers an effective and convenient option for the management of common superficial fungal infections.